爱尔眼科(300015) - 2014 Q4 - 年度业绩

Financial Performance - Total revenue for 2014 reached CNY 2,402.05 million, an increase of 21.01% compared to 2013[4] - Operating profit was CNY 429.41 million, reflecting a growth of 34.02% year-over-year[4] - Net profit attributable to shareholders was CNY 308.91 million, up 38.22% from the previous year[4] - Basic earnings per share increased to CNY 0.47, a rise of 38.24% compared to the same period last year[4] - Return on equity was 16.90%, an increase of 2.88 percentage points from the previous year[4] Assets and Equity - Total assets at the end of the reporting period were CNY 2,550.13 million, a growth of 20.36% from the beginning of the year[4] - Shareholders' equity attributable to the company reached CNY 2,024.22 million, up 21.50% from the start of the year[4] - The total share capital increased by 51.23% due to capital reserve conversion and stock option exercises[6] - The net asset value per share decreased to CNY 3.0937, down 19.66% from the beginning of the year[4] Earnings Forecast - There were no discrepancies between the reported performance and the previously announced earnings forecast[7]